Benoît Callendret

3.1k citations

49 papers · 1.6k indexed · 2 hit papers · h-index 20

Impact in

Hepatology top 2%
- Hepatitis C virus research
Infectious Diseases top 2%
- SARS-CoV-2 and COVID-19 Research
- Viral gastroenteritis research and epidemiology
- COVID-19 Clinical Research Studies

Papers in ⓘ

Infectious Diseases 29
- Viral gastroenteritis research and epidemiology 15
- Viral Infections and Outbreaks Research 11
- SARS-CoV-2 and COVID-19 Research 6
Hepatology 10
- Hepatitis C virus research 9

Co-authors: Christopher M. Walker (10 shared papers)Esther Heijnen (18 shared papers)Christy Comeaux (17 shared papers)Arangassery Rosemary Bastian (21 shared papers)William C. Satterfield (4 shared papers)Nicolas Escriou (3 shared papers)Els De Paepe (11 shared papers)Heather B. Eccleston (4 shared papers)
Journals: The Journal of Infectious Diseases (7 papers)Open Forum Infectious Diseases (4 papers)Journal of Virology (4 papers)Human Vaccines & Immunotherapeutics (3 papers)Vaccine (3 papers)
Partner nations: Netherlands United States Belgium

In The Last Decade

Benoît Callendret

47 papers receiving 1.5k citations

Hit Papers

align trajectories log scale

Efficacy and Safety of an Ad26.RSV.preF–RSV preF Protein Vaccine in Older Adults 2023 · 90 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2023 New England Journal of Medicine
2022 European Respiratory Review

Peers

Countries citing papers authored by Benoît Callendret

Since Specialization

Citations

This map shows the geographic impact of Benoît Callendret's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benoît Callendret with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benoît Callendret more than expected).

Fields of papers citing papers by Benoît Callendret

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benoît Callendret. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benoît Callendret. The network helps show where Benoît Callendret may publish in the future.

Co-authors

The 25 scholars most cited alongside Benoît Callendret, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Benoît Callendret Line = papers co-authored together Benoît Callendret links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Anti-Severe Acute Respiratory Syndrome Coronavirus Spike Antibodies Trigger Infection of Human Immune Cells via a pH- and Cysteine Protease-Independent FcγR Pathway Journal of Virology ·Martial Jaume, M Yip, Chung Yan Cheung, Nancy Leung, Ping H. Li, François Kien, Isabelle Dutry, Benoît Callendret, Nicolas Escriou, Ralf Altmeyer, Béatrice Nal, Marc Daëron, Roberto Bruzzone, Malik Peiris	2011	221
2	Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1) Proceedings of the National Academy of Sciences ·Michael J. Fuller, Benoît Callendret, Baogong Zhu, Gordon J. Freeman, Dana L. Hasselschwert, William C. Satterfield, Arlene H. Sharpe, Lynn B. Dustin, Charles M. Rice, Arash Grakoui, Rafi Ahmed, Christopher M. Walker	2013	140
3	Burden of respiratory syncytial virus infection in older and high-risk adults: a systematic review and meta-analysis of the evidence from developed countries European Respiratory Review ·Jonathan S. Nguyen‐Van‐Tam, Maureen A. O’Leary, Emily T. Martin, Esther Heijnen, Benoît Callendret, Roman Fleischhackl, Christy Comeaux, Thao Mai Phuong Tran, Karin Weber Hit paper breakdown →	2022	127
4	Novel Infectious cDNA Clones of Hepatitis C Virus Genotype 3a (Strain S52) and 4a (Strain ED43): Genetic Analyses and In Vivo Pathogenesis Studies Journal of Virology ·Judith M. Gottwein, Troels K. H. Scheel, Benoît Callendret, Yi‐Ping Li, Heather B. Eccleston, Ronald E. Engle, Sugantha Govindarajan, William C. Satterfield, Robert H. Purcell, Christopher M. Walker, Jens Bukh	2010	114
5	Efficacy and Safety of an Ad26.RSV.preF–RSV preF Protein Vaccine in Older Adults New England Journal of Medicine ·Ann R. Falsey, Kristi L. Williams, Efi Gymnopoulou, Stephan Bart, John Ervin, Arangassery Rosemary Bastian, Joris Menten, Els De Paepe, Sjouke Vandenberghe, Eric K. H. Chan, Jerald Sadoff, Macaya Douoguih, Benoît Callendret, Christy Comeaux, Esther Heijnen Hit paper breakdown →	2023	90
6	Phase 1 Safety and Immunogenicity Study of a Respiratory Syncytial Virus Vaccine With an Adenovirus 26 Vector Encoding Prefusion F (Ad26.RSV.preF) in Adults Aged ≥60 Years The Journal of Infectious Diseases ·Kristi L. Williams, Arangassery Rosemary Bastian, Robert Feldman, Edmund Omoruyi, Els De Paepe, Jenny Hendriks, Hester van Zeeburg, Olivier Godeaux, Johannes P. M. Langedijk, Hanneke Schuitemaker, Jerry Sadoff, Benoît Callendret	2020	79
7	Dominance of the CD4+ T helper cell response during acute resolving hepatitis A virus infection The Journal of Experimental Medicine ·Yan Zhou, Benoît Callendret, Dan Xu, Kathleen M. Brasky, Zongdi Feng, Lucinda Hensley, Jérémie Guedj, Alan S. Perelson, Stanley M. Lemon, Robert E. Lanford, Christopher M. Walker	2012	69
8	Prevention of Respiratory Syncytial Virus Infection in Healthy Adults by a Single Immunization of Ad26.RSV.preF in a Human Challenge Study The Journal of Infectious Diseases ·Jerald Sadoff, Els De Paepe, John P. DeVincenzo, Efi Gymnopoulou, Joris Menten, Bryan Murray, Arangassery Rosemary Bastian, An Vandebosch, Wouter Haazen, Nicolas Noulin, Christy Comeaux, Esther Heijnen, Kingsley Eze, Anthony Gilbert, Rob Lambkin‐Williams, Hanneke Schuitemaker, Benoît Callendret	2021	67
9	Stable Cytotoxic T Cell Escape Mutation in Hepatitis C Virus Is Linked to Maintenance of Viral Fitness PLoS Pathogens ·Luke S. Uebelhoer, Jin‐Hwan Han, Benoît Callendret, Guaniri Mateu, Naglaa H. Shoukry, Holly L. Hanson, Charles M. Rice, Christopher M. Walker, Arash Grakoui	2008	66
10	T-cell immunity and hepatitis C virus reinfection after cure of chronic hepatitis C with an interferon-free antiviral regimen in a chimpanzee Hepatology ·Benoît Callendret, Heather B. Eccleston, Shelby Hall, William C. Satterfield, Stefania Capone, Antonella Folgori, Riccardo Cortese, Alfredo Nicosia, Christopher M. Walker	2014	55
11	Selection-Driven Immune Escape Is Not A Significant Factor in the Failure of Cd4 T Cell Responses in Persistent Hepatitis C Virus Infection Hepatology ·Michael J. Fuller, Naglaa H. Shoukry, Toshifumi Gushima, David G. Bowen, Benoît Callendret, Katherine J. Campbell, Dana L. Hasselschwert, Austin L. Hughes, Christopher M. Walker	2009	54
12	Protection from SARS coronavirus conferred by live measles vaccine expressing the spike glycoprotein Virology ·Nicolas Escriou, Benoît Callendret, Valérie Lorin, Chantal Combredet, Philippe Marianneau, Michèle Février, Frédéric Tangy	2014	47
13	A two-dose heterologous prime-boost vaccine regimen eliciting sustained immune responses to Ebola Zaire could support a preventive strategy for future outbreaks Human Vaccines & Immunotherapeutics ·Georgi Shukarev, Benoît Callendret, Kerstin Lühn, Macaya Douoguih, (unknown)	2016	47
14	Safety and Immunogenicity of the Ad26.RSV.preF Investigational Vaccine Coadministered With an Influenza Vaccine in Older Adults The Journal of Infectious Diseases ·Jerald Sadoff, Els De Paepe, Wouter Haazen, Edmund Omoruyi, Arangassery Rosemary Bastian, Christy Comeaux, Esther Heijnen, Cynthia Strout, Hanneke Schuitemaker, Benoît Callendret	2020	42
15	Antibody effector functions are associated with protection from respiratory syncytial virus Cell ·Yannic C. Bartsch, Deniz Cizmeci, Jaewon Kang, Tomer Zohar, Sivakumar Periasamy, Nickita Mehta, Jeroen Tolboom, Leslie van der Fits, Jerry Sadoff, Christy Comeaux, Benoît Callendret, Alexander Bukreyev, Douglas A. Lauffenburger, Arangassery Rosemary Bastian, Galit Alter	2022	37
16	Phase 1/2a Safety and Immunogenicity of an Adenovirus 26 Vector Respiratory Syncytial Virus (RSV) Vaccine Encoding Prefusion F in Adults 18–50 Years and RSV-Seropositive Children 12–24 Months The Journal of Infectious Diseases ·Arabella Stuart, Miia Virta, Kristi L. Williams, Ilkka Seppä, Robyn Hartvickson, Melanie Greenland, Edmund Omoruyi, Arangassery Rosemary Bastian, Wouter Haazen, Nadine C. Salisch, Efi Gymnopoulou, Benoît Callendret, Saul N. Faust, Matthew D. Snape, Esther Heijnen	2022	28
17	Transmission of Clonal Hepatitis C Virus Genomes Reveals the Dominant but Transitory Role of CD8⁺T Cells in Early Viral Evolution Journal of Virology ·Benoît Callendret, Jens Bukh, Heather B. Eccleston, Ryan Heksch, Dana L. Hasselschwert, Robert H. Purcell, Austin L. Hughes, Christopher M. Walker	2011	26
18	Safety and Immunogenicity of Heterologous and Homologous 2-Dose Regimens of Adenovirus Serotype 26– and Modified Vaccinia Ankara–Vectored Ebola Vaccines: A Randomized, Controlled Phase 1 Study The Journal of Infectious Diseases ·Neil Goldstein, Viki Bockstal, Stephan Bart, Kerstin Lühn, Cynthia Robinson, Auguste Gaddah, Benoît Callendret, Macaya Douoguih	2020	24
19	A siege of hepatitis: Immune boost for viral hepatitis Nature Medicine ·Benoît Callendret, Christopher M. Walker	2011	19
20	First-in-human study to evaluate safety, tolerability, and immunogenicity of heterologous regimens using the multivalent filovirus vaccines Ad26.Filo and MVA-BN-Filo administered in different sequences and schedules: A randomized, controlled study PLoS ONE ·Viki Bockstal, Georgi Shukarev, Chelsea McLean, Neil Goldstein, Stephan Bart, Auguste Gaddah, Dickson Anumenden, Jeroen N. Stoop, Anne Marit de Groot, Maria Grazia Pau, Jenny Hendriks, Stephen C. De Rosa, Kristen W. Cohen, M. Juliana McElrath, Benoît Callendret, Kerstin Lühn, Macaya Douoguih, Cynthia Robinson	2022	19

About Benoît Callendret

Benoît Callendret is a scholar working on Infectious Diseases, Hepatology, Epidemiology, Animal Science and Zoology and Modeling and Simulation, having authored 49 papers that have together received 1.6k indexed citations. Recurring topics across this work include Respiratory viral infections research (25 papers), Viral gastroenteritis research and epidemiology (15 papers), Viral Infections and Outbreaks Research (11 papers), Animal Virus Infections Studies (10 papers), Hepatitis C virus research (9 papers), Hepatitis B Virus Studies (8 papers), SARS-CoV-2 and COVID-19 Research (6 papers) and Pneumonia and Respiratory Infections (6 papers). The work is most often cited by research in Hepatology (432 citations), Infectious Diseases (751 citations), Epidemiology (893 citations), Virology (99 citations) and Immunology (299 citations). Benoît Callendret has collaborated with scholars based in Netherlands, United States and Belgium. Frequent co-authors include Christopher M. Walker, Esther Heijnen, Christy Comeaux, Arangassery Rosemary Bastian, William C. Satterfield, Nicolas Escriou, Els De Paepe, Heather B. Eccleston, Macaya Douoguih and Dana L. Hasselschwert. Their work appears in journals such as The Journal of Infectious Diseases, Open Forum Infectious Diseases, Journal of Virology, Human Vaccines & Immunotherapeutics and Vaccine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact